WeightWatchers soars after Sequence acquisition

WeightWatchers soars after Sequence acquisition

5
(396)
Écrire un avis
Plus
€ 21.00
Ajouter au panier
En Stock
Description

WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.

Weight Watchers: Better-Than-Expected Q2, But Long-Term Challenges

WeightWatchers buys telehealth platform Sequence, facilitating

WW International stock soars as Sequence deal closes, Goldman

Blake Madden on LinkedIn: AI-enabled documentation player Abridge

WW Stock Soars To High. New Weight-Loss Drug Play Enjoys Oprah

Weight Watches Parent's Stock Soars Again On Obesity-Drug, Goldman

How do customer acquisition and retention fare for weight-loss

WeightWatchers stock surges after Sequence deal

WW International stock soars on acquisition deal with prescription

Ozempic craze hammers 'obesity industry': Companies behind insulin

Ozempic craze hammers 'obesity industry': Companies behind insulin

Why Ozempic isn't just getting celebrities thin: it's killing the